CD274 and head and neck squamous cell carcinoma: We also could observe higher PD-L1 TPS in CDK7-overexpressing tumors, concluding that similar pathways might facilitate immune escape in HNSCC as well, and further supporting the statement that particularly patients with high CDK7 expression might profit from immunotherapy.